Covalon Technologies Ltd.

Covalon Technologies Ltd.verified

CVALF

Price:

$1.37

Market Cap:

$54.29M

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access ...[Read more]

Industry

Biotechnology

IPO Date

2007-04-18

Stock Exchange

OTC

Ticker

CVALF

The Enterprise Value as of December 2025 (TTM) for Covalon Technologies Ltd. (CVALF) is 37.47M

According to Covalon Technologies Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.47M. This represents a change of -40.34% compared to the average of 62.81M of the last 4 quarters.

Covalon Technologies Ltd. (CVALF) Historical Enterprise Value (quarterly & annually)

How has CVALF Enterprise Value performed in the past?

The mean historical Enterprise Value of Covalon Technologies Ltd. over the last ten years is 59.10M. The current 37.47M Enterprise Value has changed 6.24% with respect to the historical average. Over the past ten years (40 quarters), CVALF's Enterprise Value was at its highest in in the September 2018 quarter at 184.73M. The Enterprise Value was at its lowest in in the September 2015 quarter at 5.13M.

Quarterly (TTM)
Annual

Average

59.10M

Median

49.41M

Minimum

5.13M

Maximum

191.32M

Covalon Technologies Ltd. (CVALF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Covalon Technologies Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 332.62%

Maximum Annual Enterprise Value = 191.32M

Minimum Annual Increase = -68.54%

Minimum Annual Enterprise Value = 5.13M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202465.46M118.62%
202329.94M-40.64%
202250.45M12.17%
202144.97M-7.04%
202048.38M-19.61%
201960.18M-68.54%
2018191.32M162.26%
201772.95M228.98%
201622.17M332.62%
20155.13M-57.20%

Covalon Technologies Ltd. (CVALF) Average Enterprise Value

How has CVALF Enterprise Value performed in the past?

The current Enterprise Value of Covalon Technologies Ltd. (CVALF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

48.62M

5-year avg

47.84M

10-year avg

59.10M

Covalon Technologies Ltd. (CVALF) Enterprise Value vs. Peers

How is CVALF’s Enterprise Value compared to its peers?

Covalon Technologies Ltd.’s Enterprise Value is greater than Relief Therapeutics Holding AG (24.05M), less than Oncotelic Therapeutics, Inc. (58.52M), greater than PsyBio Therapeutics Corp. (135.91K), less than Arch Biopartners Inc. (86.23M), less than Amplia Therapeutics Limited (53.28M), less than Helix BioPharma Corp. (178.01M), greater than Relief Therapeutics Holding AG (24.05M), less than Cynata Therapeutics Limited (59.06M), less than Sernova Corp. (47.11M), less than MedMira Inc. (59.27M),

Build a custom stock screener for Covalon Technologies Ltd. (CVALF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Covalon Technologies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Covalon Technologies Ltd. (CVALF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Covalon Technologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Covalon Technologies Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Covalon Technologies Ltd. (CVALF)?

What is the 3-year average Enterprise Value for Covalon Technologies Ltd. (CVALF)?

What is the 5-year average Enterprise Value for Covalon Technologies Ltd. (CVALF)?

How does the current Enterprise Value for Covalon Technologies Ltd. (CVALF) compare to its historical average?